Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives $30.62 Average Price Target from Analysts
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year target […]
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year target […]
